Triplet regimen yields promising response in advanced-phase chronic myeloid leukemia

Five key factors predict the response of cancer patients to immunotherapy

Experimental mRNA cancer vaccine shows potential for advanced stage cancer patients in Phase 1 trial

Neuroscientist Nathaniel Harnett unravels brain's response to trauma, advancing PTSD research - EurekAlert